Literature DB >> 12699435

The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.

Atsushi Fukao1, Junta Takamatsu, Yasuhiro Murakami, Sadaki Sakane, Akira Miyauchi, Kanji Kuma, Shunichiro Hayashi, Toshiaki Hanafusa.   

Abstract

OBJECTIVE: The relationship between emotional stress and the onset of hyperthyroidism has been well investigated, but the relationship between psychological factors and prognosis of antithyroid drug-treated hyperthyroidism is not well known. This study has examined not only emotional stresses but also patients' personality traits using specific tests.
DESIGN: A prospective cohort study.
SUBJECTS: Sixty-nine patients with hyperthyroid Graves' disease in the euthyroid state after 2-5 years of antithyroid drug therapy and 32 healthy subjects as the control group. MEASUREMENTS: Patients responded to three types of questionnaires, including the Minnesota Multiphasic Personality Inventory for personality traits, the Natsume's Stress Inventory for major life events, and the Hayashi's Daily Life Stress Inventory for daily life stresses.
RESULTS: In the Graves' disease patients, stress scores of life events correlated significantly with serum TSH receptor antibody activity (r = 0.424, P < 0.001) and thyroid volume (r = 0.480, P < 0.001). When the patients were divided according to prognosis (41 with relapse and 28 with remission), four personality traits including hypochondriasis, depression, paranoia and psychasthenia (mental fatigue) were significantly (P = 0.0146, 0.0052, 0.0125, and 0.0186, respectively) more common in the relapsed Graves' disease group than those of the remitted group. Six personality traits of conversion hysteria, psychopathic deviation, masculinity and feminity, schizophrenia, hypomania, and social introversion were not significantly different between the two groups. The scores of daily hassles (problems of daily life) were also significantly (P = 0.0124) greater in the relapsed Graves' disease group than in the remitted group. The scale scores of depression and psychasthenia showed a positive correlation with scores of daily hassles (r = 0.535, P < 0.0001; r = 0.580, P < 0.0001, respectively), while an inverse correlation with scores of daily uplifts (r = -0.373, P = 0.0332; r = -0.322, P = -0.0120, respectively).
CONCLUSIONS: The results suggest that major life events, personality traits of hypochondriasis and depression, paranoia, mental fatigue, and daily problems aggravate the prognosis of antithyroid drug-treated hyperthyroidism. Escape from life events is virtually impossible; thus coping strategies suggested by the physician may be useful in improving prognosis in Graves' disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699435     DOI: 10.1046/j.1365-2265.2003.01625.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 2.  Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

Authors:  Robertas Bunevicius; Arthur J Prange
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  [Endocrine ophthalmopathy. A visible psychophysical complaint].

Authors:  I Strempel
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

4.  A patient with stress-related onset and exacerbations of Graves disease.

Authors:  Roberto Vita; Daniela Lapa; Giuseppe Vita; Francesco Trimarchi; Salvatore Benvenga
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-25

5.  Stress and hormones.

Authors:  Salam Ranabir; K Reetu
Journal:  Indian J Endocrinol Metab       Date:  2011-01

6.  The thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment.

Authors:  Atsushi Fukao; Junta Takamatsu; Sumihisa Kubota; Akira Miyauchi; Toshiaki Hanafusa
Journal:  Biopsychosoc Med       Date:  2011-08-09

7.  The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study.

Authors:  Cheng-Chieh Chang; Szu-Ying Wu; Yun-Ru Lai; Yu-Chiang Hung; Chung Y Hsu; Hsuan-Ju Chen; Cheng-Chung Chu; Jai-Hong Cheng; Wen-Long Hu; Chun-En Aurea Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-19       Impact factor: 2.650

8.  Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre.

Authors:  Kira Bang Bové; Torquil Watt; Asmus Vogel; Laszlo Hegedüs; Jakob Bue Bjoerner; Mogens Groenvold; Steen Joop Bonnema; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen
Journal:  Eur Thyroid J       Date:  2014-09-02

9.  Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease.

Authors:  Huiling Liew; Torquil Watt; Luo Nan; Alvin W K Tan; Yiong Huak Chan; Daniel Ek Kwang Chew; Rinkoo Dalan
Journal:  J Patient Rep Outcomes       Date:  2021-07-08

10.  The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma.

Authors:  Roy Moncayo; Alexander Kroiss; Manfred Oberwinkler; Fatih Karakolcu; Matthias Starzinger; Klaus Kapelari; Heribert Talasz; Helga Moncayo
Journal:  BMC Endocr Disord       Date:  2008-01-25       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.